{"id":"NCT01964430","sponsor":"Celgene","briefTitle":"Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the \"Apact\" Study)","officialTitle":"A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03-28","primaryCompletion":"2022-06-30","completion":"2022-06-30","firstPosted":"2013-10-17","resultsPosted":"2020-01-06","lastUpdate":"2023-06-28"},"enrollment":866,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pancreatic Neoplasms","Digestive System Neoplasms","Neoplasms by Site","Neoplasms","Endocrine Gland Neoplasms","Pancreatic Diseases","Digestive System Diseases","Endocrine System Diseases","Gemcitabine","Antimetabolites, Antineoplastic"],"interventions":[{"type":"DRUG","name":"nab-Paclitaxel","otherNames":["Abraxane"]},{"type":"DRUG","name":"Gemcitabine","otherNames":["Gemzar"]}],"arms":[{"label":"nab-Paclitaxel 125 mg/m^2 plus gemcitabine 1000 mg/m2","type":"EXPERIMENTAL"},{"label":"Gemcitabine 1000 mg/m^2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in participants with surgically removed pancreatic cancer who then take nab-Paclitaxel in combination with gemcitabine compared to those who take gemcitabine alone.","primaryOutcome":{"measure":"Kaplan Meier Estimate for Disease Free Survival (DFS) According to the Independent Radiological Review Committee","timeFrame":"Date of randomization up to data cut off date of 31 December 2018; median DFS follow-up time for censored participants was 22.242 months for nab-Paclitaxel and gemcitabine and 13.832 months for gemcitabine alone","effectByArm":[{"arm":"Nab-Paclitaxel and Gemcitabine","deltaMin":19.4,"sd":null},{"arm":"Gemcitabine","deltaMin":18.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.1824"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":341,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","Finland","France","Germany","Hong Kong","Hungary","Ireland","Italy","Netherlands","Portugal","Singapore","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["29932294","30149366","30497432","30768369","36521097","33813673"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://www.BMSStudyConnect.com"]},"adverseEventsSummary":{"seriousAny":{"events":181,"n":429},"commonTop":["Neutropenia","Fatigue","Nausea","Diarrhoea","Anaemia"]}}